These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 8368634)
21. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Ishii H; Mukae H; Kadota J; Fujii T; Abe K; Ashitani J; Kohno S Respiration; 2005; 72(1):39-45. PubMed ID: 15753633 [TBL] [Abstract][Full Text] [Related]
22. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Kobayashi J; Kitamura S Chest; 1996 May; 109(5):1276-82. PubMed ID: 8625680 [TBL] [Abstract][Full Text] [Related]
23. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia. Daimon T; Tajima S; Oshikawa K; Bando M; Ohno S; Sugiyama Y Intern Med; 2005 Aug; 44(8):811-7. PubMed ID: 16157978 [TBL] [Abstract][Full Text] [Related]
24. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis. Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Honda Y; Kuroki Y; Matsuura E; Nagae H; Takahashi H; Akino T; Abe S Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1860-6. PubMed ID: 8520747 [TBL] [Abstract][Full Text] [Related]
26. Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation. Ashida T; Higashishiba M; Sumimoto Y; Sano T; Miyazato H; Shimada T; Miyatake J; Kawanishi K; Tatsumi Y; Kanamaru A Int J Hematol; 2001 Dec; 74(4):464-8. PubMed ID: 11794706 [TBL] [Abstract][Full Text] [Related]
27. [Pneumocystis carinii pneumonia associated with high levels of serum KL-6]. Kawakami R; Kikuchi K; Kobayashi J; Shibuya Y; Hagiwara S; Saku N; Hironaka M; Fujii T; Chiba Y Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34(12):1420-6. PubMed ID: 9022332 [TBL] [Abstract][Full Text] [Related]
28. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis. Inage M; Nakamura H; Kato S; Saito H; Abe S; Hino T; Tomoike H Respir Med; 2000 Feb; 94(2):155-60. PubMed ID: 10714422 [TBL] [Abstract][Full Text] [Related]
30. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease. Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238 [TBL] [Abstract][Full Text] [Related]
31. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation. Ohshimo S; Bonella F; Sommerwerck U; Teschler H; Kamler M; Jakob HG; Kohno N; Guzman J; Costabel U J Heart Lung Transplant; 2011 Dec; 30(12):1374-80. PubMed ID: 21871820 [TBL] [Abstract][Full Text] [Related]
32. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis. Cantin AM; Boileau R; Bégin R Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038 [TBL] [Abstract][Full Text] [Related]
33. KL-6: a serum marker for interstitial pneumonia. Kobayashi J; Kitamura S Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858 [TBL] [Abstract][Full Text] [Related]
35. Expression of S100A9 and KL-6 in common interstitial lung diseases. Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076 [TBL] [Abstract][Full Text] [Related]
36. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745 [TBL] [Abstract][Full Text] [Related]
37. Protein C anticoagulant system in patients with interstitial lung disease. Kobayashi H; Gabazza EC; Taguchi O; Wada H; Takeya H; Nishioka J; Yasui H; Kobayashi T; Hataji O; Suzuki K; Adachi Y Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1850-4. PubMed ID: 9620917 [TBL] [Abstract][Full Text] [Related]
38. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539 [TBL] [Abstract][Full Text] [Related]
39. Induction of angiotensin converting enzyme in cultured human monocytes by a factor present in the bronchoalveolar lavage fluid of sarcoidosis patients. Rohrbach MS; Vuk-Pavlović Z; Martin WJ; DeLaval P; Genetet N Sarcoidosis; 1988 Mar; 5(1):17-23. PubMed ID: 2837820 [TBL] [Abstract][Full Text] [Related]
40. Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis. Ishikawa N; Kondo K; Oguri T; Kamitsuna M; Sakurai J; Fujitaka K; Yamasaki M; Maeda H; Isobe T; Kohno N Intern Med; 2002 May; 41(5):381-5. PubMed ID: 12058888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]